Immune mechanisms in pain control

Anesthesia and Analgesia

Volumn 95, Issue 4, 2002, Pages 1002-1008

  Machelska, Halina ^a   Stein, Christoph ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CORTICOTROPIN RELEASING FACTOR; INTERLEUKIN 1; KAPPA OPIATE RECEPTOR AGONIST; NALOXONE; OPIATE AGONIST; OPIATE PEPTIDE; OPIATE RECEPTOR; PROENKEPHALIN; PROOPIOMELANOCORTIN;

ABDOMEN; ANALGESIA; CELL MIGRATION; CENTRAL NERVOUS SYSTEM DISEASE; DRUG ADMINISTRATION; DRUG EFFECT; DRUG MECHANISM; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPETENT CELL; INFLAMMATION; NEUROIMMUNOLOGY; NEUROPATHOLOGY; NOCICEPTION; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVIEW; SENSORY NERVE; STRESS; VASCULAR ENDOTHELIUM;

EID: 0036785727     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/00000539-200210000-00039     Document Type: Review

References (70)

1. Stein C, Hassan AHS, Przewlocki R, et al. Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc Natl Acad Sci USA 1990;87: 5935-9.
2. Hassan AHS, Ableitner A, Stein C, Herz A. Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue. Neuroscience 1993;55:185-95.
3. Ji R-R, Zhang Q, Law P-Y, et al. Expression of μ-, δ-, and κ-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation. J Neurosci 1995; 15:8156-66.
4. Mansour A, Fox CA, Akil H, Watson SJ. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci 1995;18:22-9.
5. Coggeshall RE, Zhou S, Carlton SM. Opioid receptors on peripheral sensory axons. Brain Res 1997;764:126-32.
6. Mousa SA, Zhang Q, Sitte N, et al. β-Endorphin containing memory-cells and μ-opioid receptors undergo site-directed transport into peripheral inflamed tissue. J Neuroimmunol 2001;115:71-8.
7. Pare M, Elde R, Mazurkiewicz JE, et al. The Meissner corpuscle revised: a multiafferented mechanoreceptor with nociceptor immunochemical properties. J Neurosci 2001;21:7236-46.
8. Stein C, Pflüger M, Yassouridis A, et al. No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia. J Clin Invest 1996;98:793-9.
9. Zhou L, Zhang Q, Stein C, Schäfer M. Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia. J Pharmacol Exp Ther 1998;261:1-7.
10. Stein C. Opioid receptors on peripheral sensory neurons. In: Machelska H, Stein C, eds. Immune mechanisms of pain and analgesia. Georgetown, TX: Landes Bioscience. 2002:69-73.
11. Wenk HN, Honda CN. Immunohistochemical localization of delta opioid receptors in peripheral tissues. J Comp Neurol 1999;408:567-79.
12. Zhang Q, Schäfer M, Elde R, et al. Effects of neurotoxins and hindpaw inflammation on opioid receptor immunoreactivities in dorsal root ganglia. Neuroscience 1998;85:281-91.
13. Bryant HU, Holaday JW. Opioids in immunologic processes. In: Herz A, ed. Opioids II. Berlin, Germany: Springer-Verlag, 1993: 551-70.
14. Sharp BM. Opioid receptor expression and intracellular signaling by cells involved in host defence and immunity. In: Machelska H, Stein C, eds. Immune mechanisms of pain and analgesia. Georgetown, TX: Landes Bioscience. 2002:98-103.
15. Panerai AE, Sacerdote P. β-endorphin in the immune system: a role at last? Immunol Today 1997;18:317-9.
16. Sacerdote P, Limiroli E, Gaspani L. Experimental evidence for immunomodulatory effects of opioids. In: Machelska H, Stein C, eds. Immune mechanisms of pain and analgesia. Georgetown, TX: Landes Bioscience. 2002:106-12.
17. Schäfer M, Imai Y, Uhl GR, et al. Inflammation enhances peripheral μ-opioid receptor-mediated analgesia, but not μ-opioid receptor transcription in dorsal root ganglia. Eur J Pharmacol 1995;279:165-9.
18. Selley DE, Breivogel CS, Childers SR. Modification of G protein-coupled functions by low pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins. Mol Pharmacol 1993;44:731-41.
19. Antonijevic I, Mousa SA, Schäfer M, et al. Perineurial defect and peripheral opioid analgesia in inflammation. J Neurosci 1995; 15:165-72.
20. Law P-Y, Wong YH, Loh HH. Molecular mechanisms and regulation of opioid receptor signaling. Annu Rev Pharmacol Toxicol 2000;40:389-430.
21. Akins PT, McCleskey EW. Characterization of potassium currents in adult rat sensory neurons and modulation by opioids and cyclic AMP. Neuroscience 1993;56:759-69.
22. Fan SF, Crain SM. Dual regulation by mu, delta and kappa opioid receptor agonists of K+ conductance of DRG neurons and neuroblastoma X DRG neuron hybrid F11 cells. Brain Res 1995;696:97-105.
23. Machelska H, Binder W, Stein C. Opioid receptors in the periphery. In: Kalso E, McQuay HJ, Wiesenfeld-Hallin Z, eds. Opioid sensitivity of chronic non-cancer pain. Seattle, WA: IASP Press, 1999:45-58.
24. Stein C, Schäfer M, Cabot PJ, et al. Peripheral opioid analgesia. Pain Rev 1997;4:171-85.
25. Stein C, Machelska H, Binder W, et al. Peripheral opioid analgesia. Curr Opin Pharmacol 2001;1:62-5.
26. Schäfer M. Peripheral opioid analgesia: from experimental to clinical studies. Curr Opin Anaesth 1999;12:603-7.
27. Brower V. New paths to pain relief. Nat Biotechnol 2000;18: 387-91.
28. Binder W, Machelska H, Mousa S, et al. Analgesic and anti-inflammatory effects of two novel kappa opioid peptides. Anesthesiology 2001;94:1034-44.
29. Stein A, Yassouridis A, Szopko C, et al. Intraarticular morphine versus dexamethasone in chronic arthritis. Pain 1999;83:525-32.
30. Reuben SS, Vieira P, Faruqi S, et al. Local administration of morphine for analgesia after iliac bone graft harvest. Anesthesiology 2001;95:390-4.
31. Höllt V. Opioid peptide processing and receptor selectivity. Annu Rev Pharmacol Toxicol 1986;26:59-77.
32. Zadina JE, Hackler L, Ge L-J, Kastin AJ. A potent and selective endogenous agonist for the μ-opiate receptor. Nature 1997;386: 499-502.
33. Ottaviani E, Franchini A, Franceschi C. Pro-opiomelanocortin-derived peptides, cytokines, and nitric oxide in immune responses and stress: an evolutionary approach. Int Rev Cytol 1997;170:79-141.
34. Blalock JE. The syntax of immune-neuroendocrine communication. Immunol Today 1994;15:504-11.
35. Smith EM. Opioid peptides in immune cells. In: Machelska H, Stein C, eds. Immune mechanisms of pain and analgesia. Georgetown, TX: Landes Bioscience. 2002:51-63.
36. Jessop DS, Major GN, Coventry TL, et al. Novel opioid peptides endomorphin-1 and endomorphin-2 are present in mammalian immune tissues. J Neuroimmunol 2000;106:53-9.
37. Stefano GB, Cadet P, Rialas CM, et al. Invertebrate opiate immune and neural signaling. In: Machelska H, Stein C, eds. Immune mechanisms of pain and analgesia. Georgetown, TX: Landes Bioscience. 2002:126-41.
38. Lacaze-Masmonteil T, de Keyzer Y, Luton JP, et al. Characterization of proopiomelanocortin transcripts in human nonpituitary tissues. Proc Natl Acad Sci USA 1987;84:7261-5.
39. Buzzetti R, McLoughlin L, Lavender PM, et al. Expression of pro-opiomelanocortin gene and quantification of adrenocorticotropic hormone-like immunoreactivity in human normal peripheral mononuclear cells and lymphoid and myeloid malignancies. J Clin Invest 1989;83:733-7.
40. Galin FS, LeBoeuf RD, Blalock JE. Corticotropin-releasing factor upregulates expression of two truncated pro-opiomelanocortin transcripts in murine lymphocytes. J Neuroimmunol 1991;31: 51-8.
41. Lyons PD, Blalock JE. Pro-opiomelanocortin gene expression and protein processing in rat mononuclear leukocytes. J Neuroimmunol 1997;78:47-56.
42. Weisinger G. The transcriptional regulation of the preproenkephalin gene. Biochem J 1995;307:617-29.
43. Linner KM, Quist HE, Sharp BM. Expression and function of proenkephalin A messenger ribonucleic acid in murine fetal thymocytes. Endocrinology 1996;137:857-63.
44. Martin J, Prystowsky MB, Angeletti RH. Preproenkephalin mRNA in T-cells, macrophages, and mast cells. J Neurosci Res 1987;18:82-7.
45. Vindrola O, Mayer AMS, Citera G, et al. Prohormone convertases PC2 and PC3 in rat neutrophils and macrophages. Neuropeptides 1994;27:235-44.
46. Stein C. Mechanisms of disease: the control of pain in peripheral tissue by opioids. N Engl J Med 1995;332:1685-90.
47. Machelska H, Stein C. Pain control by immune-derived opioids. Clin Exp Pharmacol Physiol 2000;27:533-6.
48. Cabot PJ, Carter L, Gaiddon C, et al. Immune cell-derived β-endorphin: production, release and control of inflammatory pain in rats. J Clin Invest 1997;100:142-8.
49. Cabot PJ, Carter L, Schafer M, Stein C. Methionine-enkephalin and Dynorphin A-release from immune cells and control of inflammatory pain. Pain 2001;93:207-12.
50. Przewlocki R, Hassan AHS, Lason W, et al. Gene expression and localization of opioid peptides in immune cells of inflamed tissue: functional role in antinociception. Neuroscience 1992;48: 491-500.
51. Hassan AHS, Przewlocki R, Herz A, Stein C. Dynorphin, a preferential ligand for kappa-opioid receptors, is present in nerve fibers and immune cells within inflamed tissue of the rat. Neurosci Lett 1992;140:85-8.
52. Rittner HL, Brack A, Machelska H, et al. Opioid peptide expressing leukocytes-identification, recruitment and simultaneously increasing inhibition of inflammatory pain. Anesthesiology 2001;95:500-8.
53. Butcher EC, Picker LJ. Lymphocyte homing homeostasis. Science 1996;272:60-6.
54. Petruzzelli L, Takami M, Humes D. Structure and function of cell adhesion molecules. Am J Med 1999;106:467-76.
55. Mousa SA, Machelska H, Schäfer M, Stein C. Co-expression of β-endorphin with adhesion molecules in a rat model of inflammatory pain. J Neuroimmunol 2000;108:160-70.
56. Machelska H, Cabot PJ, Mousa SA, et al. Pain control in inflammation governed by selectins. Nat Med 1998;4:1425-8.
57. Schafer M, Mousa SA, Stein C. Corticotropin-releasing factor in antinociception and inflammation. Eur J Pharmacol 1997;323: 1-10.
58. Mousa SA, Schafer M, Mitchell WM, et al. Local upregulation of corticotropin-releasing hormone and interleukin-1 receptors in rats with painful hindlimb inflammation. Eur J Pharmacol 1996; 311:221-31.
59. Radulovic M, Dautzenberg FM, Sydow S, et al. Corticotropin-releasing factor receptor 1 in mouse spleen: expression after immune stimulation and identification of receptor-bearing cells. J Immunol 1999;162:3013-21.
60. Schäfer M, Carter L, Stein C. Interleukin-1β and corticotropin-releasing-factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc Natl Acad Sci USA 1994;91: 4219-23.
61. Hargreaves KM, Dubner R, Costello AH. Corticotropin releasing factor (CRF) has a peripheral site of action for antinociception. Eur J Pharmacol 1989;170:275-9.
62. Ferreira SH, Lorenzetti BB, Bristow AF, et al. Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 1988;334:698-700.
63. Cunha FQ, Ferreira SH. Peripheral hyperalgesic cytokines. In: Machelska H, Stein C, eds. Immune mechanisms of pain and analgesia. Georgetown, TX: Landes Bioscience. 2002:22-34.
64. Stein C, Gramsch C, Herz A. Intrinsic mechanisms of antinociception in inflammation: local opioid receptors and betaendorphin. J Neurosci 1990;10:1292-8.
65. Schäfer M, Mousa SA, Zhang Q, et al. Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia. Proc Natl Acad Sci USA 1996;93:6096-100.
66. Schäfer M, Binder W, Mousa S, Stein C. Peripheral opioid analgesia and sympathetic nervous system. Anesth Analg 2000;90: S338.
67. Stein C, Comisel K, Haimerl E, et al. Analgesic effect of intraarticular morphine after arthroscopic knee surgery. N Engl J Med 1991;325:1123-6.
68. Stein C, Hassan AHS, Lehrberger K, et al. Local analgesic effect of endogenous opioid peptides. Lancet 1993;342:321-4.
69. Merine DS, Fishman EK, Jones B, et al. Right lower quadrant pain in the immunocompromised patient: CT findings in 10 cases. Am J Roentgenol 1987;149:1177-9.
70. Lefkowitz M. Pain management for the AIDS patients. J Fla Med Assoc 1996;31:701-4.